Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Prehabililtation in Retroperitoneal Sarcomas.

Created on 13 Jul 2026

Authors

Eyal Mor, Hayden Snow, Jenelle Loeliger, Bernhard Riedel, Maria Ftanou, Linda Denehy, Emily Traer, Tara Dehm, Hilmy Ismail, David E Gyorki, Centre for Prehabilitation Peri‐operative Care (CPPOC)

Published in

Journal of surgical oncology. Jul 12, 2026. Epub Jul 12, 2026.

Abstract

Retroperitoneal sarcoma (RPS) requires complex surgery with high post-operative morbidity. Prehabilitation aims to optimize the physical, psychological, and nutritional status of high-risk patients before surgery. This study outlines our experience with a multimodal prehabilitation program for RPS patients.
We retrospectively analyzed 41 patients who underwent RPS resection and participated in prehabilitation (2020-2023) at a tertiary center, describing assessment findings and peri-operative outcomes.
A total of 41 patients were included in the analysis out of 132 patients who had surgery for RPS during the specified time period. All participated in a multimodal prehabilitation program, including physical, nutritional, and psychological support. The average program duration was 57 days (range, 42-132). Among 36 (88%) who completed cardiopulmonary exercise testing, the mean respiratory exchange ratio was 1.15 (±0.2), and peak vO2 was 14.9 (±4.1) mls/kg/min. Mean Australia-modified Karnofsky Performance Status (AKPS) was 85 (±10). Seventeen (41%) had an MST score ≥2, indicating malnutrition risk. Mean operative time was 5.7 (±2.4) hours; hospital and ICU stays averaged 12.5 (±8.1) and 1.3 (±1.6) days. Major post-operative complications (Clavien-Dindo ≥ 3) occurred in 9 patients (21%), with 2 (4%) requiring re-operation.
A Multimodal prehabililtation program in retroperitoneal sarcoma is feasible and may be worthwhile for patients at high-risk of perioperative complications.

PMID:
42437517
Bibliographic data and abstract were imported from PubMed on 13 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 2
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement